Skip to main content
SNOA
NASDAQ Industrial Applications And Services

Sonoma Pharmaceuticals Secures Manufacturing and Supply Agreement with Kenvue Brands

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.4
Mkt Cap
$3.963M
52W Low
$1.75
52W High
$6.92
52W Position info
37% above low
Off High info
65% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

SNOA sits 37% above its 52-week low of $1.75.

Summary

Sonoma Pharmaceuticals has entered into a manufacturing and supply agreement with Kenvue Brands LLC for its Microcyn technology-based products, providing a new revenue stream for the financially challenged company.


Key Events · Financing and Capital Events · SNOA

  • New Manufacturing Agreement

    Sonoma Pharmaceuticals has entered into a Manufacturing and Supply Agreement with Kenvue Brands LLC, a major consumer health company.

  • Product Scope

    The agreement focuses on the manufacturing and supply of Microcyn technology-based products for sale in the United States.

  • Agreement Term

    The initial term of the agreement is from October 24, 2025, through March 2027, with provisions for up to two additional one-year extensions upon mutual agreement.

  • Strategic Importance

    This partnership is a significant positive development for Sonoma, especially given its recent 'going concern' warning, as it provides a new revenue stream and strengthens its market position.


Analysis · SNOA · Industrial Applications And Services

Sonoma Pharmaceuticals, a company recently flagged with a going concern warning, has entered into a significant manufacturing and supply agreement with Kenvue Brands LLC. This partnership, covering Microcyn technology-based products in the United States, represents a crucial new revenue opportunity and a vote of confidence from a major consumer health company. While specific financial terms and revenue projections are not disclosed, securing such a deal provides a vital lifeline and potential for operational stability, directly addressing the company's previously reported financial viability concerns. The multi-year term, with options for extension, offers a degree of mid-term predictability for Sonoma's operations.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SNOA was trading at $2.40 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4M. The 52-week trading range was $1.75 to $6.92. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SNOA - Latest Insights

SNOA
Nov 13, 2026, 4:31 PM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $1.09
Real-time Price: $0.810 info
Change: -$0.280 (-26%) info
Market Cap: $3.654M info
SNOA
Nov 10, 2026, 4:13 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.15
Real-time Price: $0.810 info
Change: -$0.3376 (-29%) info
Market Cap: $3.654M info
SNOA
Nov 10, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $0.810 info
Change: -$0.330 (-29%) info
Market Cap: $3.654M info
SNOA
Aug 06, 2026, 9:07 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $0.810 info
Change: -$0.350 (-30%) info
Market Cap: $3.654M info
SNOA
Aug 06, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $0.810 info
Change: -$0.390 (-32%) info
Market Cap: $3.654M info